Teresa Brophy Bair sold $398K of Kura Oncology (KURA)

Executed Aug 19, disclosed Aug 21, 2 days later.

Value, as filed

$398K

31,487 sh × $12.63

Executed

Aug 19

the trade date, as filed

Disclosed

Aug 21

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

TB Teresa Brophy Bair Chief Legal Officer profile →

Teresa Brophy Bair (Chief Legal Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Kura Oncology, Inc. (KURA). The largest single filing was $398K of KURA (31,487 sh × $12.63, as filed), executed Aug 19.

The name

KURA Kura Oncology, Inc. KURA · Healthcare · 13 filings in 24 months ticker →

Healthcare · Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→